Related Experiment Video
Updated: Jun 14, 2026
11:06
Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
Published on: January 31, 2022
Psychological presentations without hepatic involvement in Wilson disease
Jainn-Jim Lin1, Kuang-Lin Lin, Huei-Shyong Wang
1Division of Pediatric Neurology, Department of Pediatrics, Chang Gung Children's Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan. lincgh@adm.cgmh.org.tw
Pediatric Neurology
|September 26, 2006
Summary
Wilson disease, a rare genetic disorder affecting copper metabolism, can present with unusual psychological symptoms and neurological issues, even without liver damage. Early diagnosis and treatment are crucial for managing this condition and improving patient outcomes.
Area of Science:
- Genetics and Metabolism
- Neurology
- Hepatology
Background:
- Wilson disease is an inherited disorder of copper metabolism.
- It typically causes neurological and hepatic symptoms.
- Early diagnosis and treatment are vital for a good prognosis.
Observation:
- This case report details a male patient with Wilson disease.
- His presentation was unusual, featuring psychological manifestations without liver involvement.
- He was initially misdiagnosed with attention-deficit hyperactivity disorder and a seizure disorder.
Findings:
- Brain imaging was key in diagnosing Wilson disease in this patient.
- The case highlights the diverse clinical presentations of Wilson disease.
- Psychological symptoms can be the primary indicator in some Wilson disease cases.
Implications:
- This case underscores the importance of considering Wilson disease in patients with unexplained neurological and psychiatric symptoms.
- It emphasizes the need for comprehensive diagnostic approaches beyond typical presentations.
- Recognizing atypical Wilson disease presentations can lead to earlier intervention and better patient management.
Related Concept Videos
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
01:16Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...